Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6).
Kristina Secnik BoyeJiat Ling PoonLaura Fernández LandóHélène SapinRuth HuhMianbo WangSuzanne WilliamsonHiren PatelPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
In adult patients with T2D and inadequate glycaemic control with basal insulin, tirzepatide treatment was associated with greater improvements in HRQoL than prandial insulin therapy in addition to clinically significant improvements in glycaemic and body weight-related parameters.